DEALER]1Call Option Transaction • August 13th, 2024 • Ani Pharmaceuticals Inc • Pharmaceutical preparations
The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the call option transaction entered into between [DEALER] (“Dealer”) and ANI Pharmaceuticals, Inc. (“Counterparty”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. Each party further agrees that this Confirmation together with the Agreement evidence a complete binding agreement between Counterparty and Dealer as to the subject matter and terms of the Transaction to which this Confirmation relates, and shall supersede all prior or contemporaneous written or oral communications with respect thereto.
ANI Pharmaceuticals, Inc. and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of August 13, 2024 2.25% Convertible Senior Notes due 2029Indenture • August 13th, 2024 • Ani Pharmaceuticals Inc • Pharmaceutical preparations • New York
INDENTURE, dated as of August 13, 2024, between ANI Pharmaceuticals, Inc., a Delaware corporation, as issuer (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”).
CREDIT AGREEMENT among ANI PHARMACEUTICALS, INC., as Lead Borrower,Credit Agreement • August 13th, 2024 • Ani Pharmaceuticals Inc • Pharmaceutical preparations • New York
CREDIT AGREEMENT, dated as of August 13, 2024, by and among ANI PHARMACEUTICALS, Inc., a Delaware corporation (the “Lead Borrower”), ANIP ACQUISITION COMPANY, a Delaware corporation (the “Initial Subsidiary Borrower”), the Additional Subsidiary Borrowers (as hereinafter defined), the Guarantors (as hereinafter defined), the Lenders (as hereinafter defined), and JPMORGAN CHASE BANK, N.A., as administrative agent for the Lenders hereunder (in such capacity, the “Administrative Agent”).
